[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

Thomas Walter, Henning Jann, Catherine Ansquer, Emmanuel Deshayes, Rocio Garcia-Carbonero, Alexandre Teulé, Richard P Baum, Hein J Verberne, Jarosław B Ćwikła, Rajaventhan Srirajaskanthan, Louis de Mestier, Chiara M Grana, Andreas Buck, Dieter Hörsch, Marianne Pavel, Lawrence O Dierickx, Michael Michael, Jonathan Strosberg, Attila Kollár, Paula Jimenez-Fonseca, Anja Rinke, Maribel del Olmo-García, Anthime Flaus, Jorge Hernando, Andreas Kluge, Monika Breuninger, Serhii Melnyk, Konstantin Zhernosekov, Jaume Capdevila

Open source

DOI: 10.1016/s0140-6736(26)00604-5
Published: 2026-07
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-00604-5,
  title = {[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial},
  author = {Thomas Walter and Henning Jann and Catherine Ansquer and Emmanuel Deshayes and Rocio Garcia-Carbonero and Alexandre Teulé and Richard P Baum and Hein J Verberne and Jarosław B Ćwikła and Rajaventhan Srirajaskanthan and Louis de Mestier and Chiara M Grana and Andreas Buck and Dieter Hörsch and Marianne Pavel and Lawrence O Dierickx and Michael Michael and Jonathan Strosberg and Attila Kollár and Paula Jimenez-Fonseca and Anja Rinke and Maribel del Olmo-García and Anthime Flaus and Jorge Hernando and Andreas Kluge and Monika Breuninger and Serhii Melnyk and Konstantin Zhernosekov and Jaume Capdevila},
  year = {2026},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(26)00604-5},
  url = {https://doi.org/10.1016/s0140-6736(26)00604-5}
}

RIS

TY  - JOUR
TI  - [177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
AU  - Thomas Walter
AU  - Henning Jann
AU  - Catherine Ansquer
AU  - Emmanuel Deshayes
AU  - Rocio Garcia-Carbonero
AU  - Alexandre Teulé
AU  - Richard P Baum
AU  - Hein J Verberne
AU  - Jarosław B Ćwikła
AU  - Rajaventhan Srirajaskanthan
AU  - Louis de Mestier
AU  - Chiara M Grana
AU  - Andreas Buck
AU  - Dieter Hörsch
AU  - Marianne Pavel
AU  - Lawrence O Dierickx
AU  - Michael Michael
AU  - Jonathan Strosberg
AU  - Attila Kollár
AU  - Paula Jimenez-Fonseca
AU  - Anja Rinke
AU  - Maribel del Olmo-García
AU  - Anthime Flaus
AU  - Jorge Hernando
AU  - Andreas Kluge
AU  - Monika Breuninger
AU  - Serhii Melnyk
AU  - Konstantin Zhernosekov
AU  - Jaume Capdevila
PY  - 2026
JO  - The Lancet
DO  - 10.1016/s0140-6736(26)00604-5
UR  - https://doi.org/10.1016/s0140-6736(26)00604-5
ER  -

APA

Walter, T., Jann, H., Ansquer, C., Deshayes, E., Garcia-Carbonero, R., Teulé, A., Baum, R. P., Verberne, H. J., Ćwikła, J. B., Srirajaskanthan, R., Mestier, L. D., Grana, C. M., Buck, A., Hörsch, D., Pavel, M., Dierickx, L. O., Michael, M., Strosberg, J., Kollár, A., Jimenez-Fonseca, P., Rinke, A., Olmo-García, M. D., Flaus, A., Hernando, J., Kluge, A., Breuninger, M., Melnyk, S., Zhernosekov, K., & Capdevila, J. (2026). [177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial. The Lancet. https://doi.org/10.1016/s0140-6736(26)00604-5

Source records

crossref · retrieved 2026-09-25T17:25:11.095Z